Genzyme to Reopen Enrollment in Alglucosidase Alfa Temporary Access Program
The Earth Times Online Newspaper (Free subscription) | yesterday
CAMBRIDGE, Mass. - Genzyme Corporation (Nasdaq: GENZ) announced today that it will reopen
Genzyme
4Vote!
5Vote!
Genzyme Begins Shipping Newly Produced Cerezyme from Allston Plant
Business Wire (Free subscription) | 12/01/2009
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme Corporation (NASDAQ: GENZ) announced today that it has begun shipping vials of newly produced Cerezyme® (imiglucerase for injection) manufactured at its Allston Landing plant. The company also provided an update on its progress to restore supplies of Cerezyme and Fabrazyme® (agalsidase beta) for patients worldwide. The initial Cerezyme shipments will...
- Genzyme Begins Shipping from Allston Plant - Contract Pharma Breaking News
Videos
5Vote!
Wall St Sense: Wall St Sense Reviews Key Players in the Basic Materials, Healthcare, Technology and Utilities Sectors
Market Wire (Free subscription) | 12/01/2009
NEW DELHI, INDIA (MARKET WIRE) U.S. stocks pushed down on "Black Friday" after Dubai State owned "Dubai World" spark fear of default on Monday. In shorten trading session, investors worried. As new market updates continue to fuel the current trading trend, Wall Street Sense analysts have issued valuable analysis on the following companies: EnCana Corporation (NYSE: ECA), E. I. du...
4Vote!
Genzyme Announces Results Of Phase 2/3 Trial Of Advanced Phosphate Binder
Medical News Today (Free subscription) | 11/20/2009
Genzyme Corporation (Nasdaq: GENZ) reported results of a phase 2/3 study of its advanced phosphate binder (APB). The trial met its primary endpoint, which was to show that the APB lowered phosphate levels effectively compared to placebo. However, the APB did not show a significant improvement in phosphate lowering compared to Genzyme's Renvela® (sevelamer carbonate). Based on these results, the...
5Vote!
Genzyme Announces Results of Phase 2/3 Trial of Advanced Phosphate Binder
Business Wire (Free subscription) | 11/18/2009
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme Corporation (Nasdaq: GENZ) today reported results of a phase 2/3 study of its advanced phosphate binder (APB). The trial met its primary endpoint, which was to show that the APB lowered phosphate levels effectively compared to placebo. However, the APB did not show a significant improvement in phosphate lowering compared to Genzyme’s Renvela® (sevelamer...
5Vote!
Genzyme Receives Complete Response Letter on Lumizyme Application
Business Wire (Free subscription) | 11/16/2009
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme Corporation (Nasdaq: GENZ) announced today that it has received a complete response letter from the FDA regarding its application to market Lumizyme™ (alglucosidase alfa) for the treatment of Pompe disease. In its letter, the agency stated that satisfactory resolution of deficiencies related to the Allston Landing manufacturing plant are required before...
4Vote!
Webcast Alert: Isis Pharmaceuticals and Genzyme Corporation to Present Mipomersen Phase 3 Data in HoFH During AHA
PR News Wire (Free subscription) | 11/11/2009
CARLSBAD, Calif., Nov. 11 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) and Genzyme Corporation (Nasdaq: GENZ) announce the following webcast:
4Vote!
Marsha Fanucci Joins Ironwood Board of Directors
PR News Wire (Free subscription) | 10/27/2009
CAMBRIDGE, Mass., Oct. 27 /PRNewswire/ -- Ironwood Pharmaceuticals, Inc. today announced that Marsha Fanucci has joined its Board of Directors. Ms. Fanucci served at Millennium Pharmaceuticals, Inc. from 2000-2009 in a number of senior positions, including chief financial officer and senior vice president of strategy, vice president of finance and strategy, and vice president of corporate development...
5Vote!
Zacks Sell List Highlights: Pinnacle Financial Partners, Marten Transport Ltd., Genzyme Corporation and MDS Inc.
Business Wire (Free subscription) | 10/23/2009
CHICAGO--(BUSINESS WIRE)--Zacks.com releases details on a group of stocks that are currently members of the exclusive Zacks #5 Rank List – Stocks to Sell Now. These stocks are currently rated as a Zacks Rank #5 (Strong Sell): Pinnacle Financial Partners (Nasdaq: PNFP) and Marten Transport Ltd. (Nasdaq: MRTN). Further, Zacks announced #4 Rankings (Sell) on two other widely held stocks: Genzyme...
4Vote!
First Patient Enrolled In Phase 3 Trials Of Genzyme Oral Capsule For Gaucher Disease
Medical News Today (Free subscription) | 10/22/2009
Genzyme Corporation (NASDAQ: GENZ) announced that the company has begun enrollment in the first of two global, multi-center, phase 3 trials of Genz-112638, a potential new oral therapy for Gaucher disease type 1. The two multi-national, multi-center trials are being conducted to evaluate the safety and efficacy of the small molecule.
7Vote!
Genzyme Corporation Q3 2009 Earnings Call Transcript
SeekingAlpha.com (Free subscription) | 10/22/2009
Genzyme Corporation ( GENZ ) Q3 2009 Earnings Call Transcript October 21, 2009 11:00 am ET Complete Story »
4Vote!
First Patient Enrolled in Phase 3 Trials of Genzyme Oral Capsule for Gaucher Disease
Business Wire (Free subscription) | 10/20/2009
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme Corporation (NASDAQ: GENZ) today announced that the company has begun enrollment in the first of two global, multi-center, phase 3 trials of Genz-112638, a potential new oral therapy for Gaucher disease type 1. The two multi-national, multi-center trials are being conducted to evaluate the safety and efficacy of the small molecule. The first trial, known as...
5Vote!
NASDAQ 100 components and analyst ratings
Cara Community - Comments (Free subscription) | 10/15/2009
In reply to Cara's Commentary & Community Chat, Thursday, Oct. 15, 2009 : Rating Company Name Symbol 1.0 Ryanair Holdings plc RYAAY 1.4 Stericycle, Inc. SRCL 1.5 Activision Blizzard, Inc ATVI 1.6 Teva Pharmaceutical Industries Limited TEVA 1.6 Warner Chilcott plc WCRX 1.7 Cognizant Technology Solutions Corp CTSH 1.7 Express Scripts, Inc. ESRX 1.7 Gilead Sciences, Inc. GILD 1.8 Foster Wheeler AG....
Explore : Aerospace and Defense, Altera Corporation, Apollo Group, Automatic Data Processing, Baidu, Biotechnologies, Business, Cable TV Networks industry, Celgene Corporation, Cisco Systems, Cognizant Technology Solutions Corp., Comcast Corporation, Computer industry, Construction, Costco Wholesale Corporation, DENTSPLY International Inc., Discount Stores, Drug Manufacturers, Education, Foster Wheeler AG, Health Industries, Intel Corp., KLA-Tencor Corporation, LAM Research Corporation, Media, Medical Equipment, Microsoft Corporation, Microsoft Yahoo, Network Equipment, Oracle Corporation, Research in Motion Ltd., Retailers, Ryanair Holdings plc, Seagate Technology, Search Engines, Semi Conductors, Software industry, Starbucks Corporation, Storage, Symantec Corporation, Technology, Telecommunication, Telecommunication Companies, Vertex Pharmaceuticals Incorporated
5Vote!
Scientists Name Genzyme a Top Employer
Business Wire (Free subscription) | 10/14/2009
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme Corporation (Nasdaq: GENZ) announced today that scientists have again named the company a top employer in a survey ranking the reputations of biotechnology and pharmaceutical companies. Genzyme is ranked third on the global list of 575 companies, the second consecutive year it has achieved this position. Genzyme placed among the top 10 of all biotechnology...
4Vote!
Genzyme Receives FDA Complete Response Letter For Clolar
Medical News Today (Free subscription) | 10/08/2009
Genzyme Corporation (Nasdaq: GENZ) announced that the FDA provided a complete response letter regarding the company's supplemental New Drug Application for Clolar® (clofarabine) in previously untreated older adult patients with acute myeloid leukemia (AML) and at least one unfavorable baseline prognostic factor.